Campath
Term · Oncology and biomedicine · MLC-T-ONC-001354
A drug used to treat B-cell chronic lymphocytic leukemia. It is also being studied in the treatment of other types of cancer. Campath binds to a protein called CD52, which is found on some types of immune cells and cancer cells. This may help the immune system kill cancer cells. Campath is a type of monoclonal antibody. Also called alemtuzumab.
| Identifier | MLC-T-ONC-001354 |
|---|---|
| Field | Oncology and biomedicine |
| Synonyms | alemtuzumab |
| References | NCI Dictionary of Cancer Terms |
Record as JSON
{
"id": "MLC-T-ONC-001354",
"term": "Campath",
"field": "Oncology and biomedicine",
"definition": "A drug used to treat B-cell chronic lymphocytic leukemia. It is also being studied in the treatment of other types of cancer. Campath binds to a protein called CD52, which is found on some types of immune cells and cancer cells. This may help the immune system kill cancer cells. Campath is a type of monoclonal antibody. Also called alemtuzumab.",
"synonyms": [
"alemtuzumab"
],
"references": [
"NCI Dictionary of Cancer Terms"
],
"url": "https://mlchart.com/terminology/oncology/campath/"
}
Record 4,053 of 17,721 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.